Intelligent Bio Solutions (INBS) Stock: Buy, Sell, or Hold?
INBS - Intelligent Bio Solutions Inc. Common Stock
$1.59
-0.09 (-5.64%)
âŧ
5d:
+6.0%
30d:
-7.02%
90d:
-7.56%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 11, 2026
17d
Get Alerted When INBS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: INBS is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: INBS is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: INBS is currently trading at $1.59, which is considered slightly low relative to its 30-day fair value range of $1.51 to $1.83. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.3) compared to its historical average (13.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INBS is in a downtrend. Immediate support is located at $1.35, while resistance sits at $1.77. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: INBS scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+654.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INBS is in a downtrend. Immediate support is located at $1.35, while resistance sits at $1.77. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: INBS scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+654.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.51 -
$1.83
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (26/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.6%)
- BULLISH: Trading 654.7% below Wall St target ($12.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.51 -
$1.83
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.35
Resistance Level
$1.77
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.31
Wall Street Target
$12.00
(+654.7%)
Revenue Growth (YoY)
35.8%
Profit Margin
-294.9%
PE vs Historical
-0.3 vs 13.0
CHEAP
Share & Embed Analysis
Last updated: October 24, 2026 4:12 AM ET
Data refreshes hourly during market hours. Next update: 5:12 AM
Data refreshes hourly during market hours. Next update: 5:12 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 52 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |